BioCentury | Jan 13, 2021
Finance
IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies
...engineering tech in November 2019 by buying CytoCardia Inc., a company spun out of the University of Washington.As...